Abstract
Motor neuron diseases such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy cause progressive paralysis, often leading to premature death. Neurotrophic factors have been suggested as therapeutic agents for motor neuron diseases, but their clinical use as injected recombinant protein was limited by toxicity and/or poor bioavaiiability. We demonstrate here that adenovirus-mediated gene transfer of neurotrophin-3 (NT-3) can produce substantial therapeutic effects in the mouse mutant pmn (progressive motor neuronopathy). After intramuscular injection of the NT-3 adenoviral vector, pmn mice showed a 50% increase in life span, reduced loss of motor axons and improved neuromuscular function as assessed by electromyography. These results were further improved by coinjecting an adenoviral vector coding for ciliary neurotrophic factor. Therefore, adenovirus-mediated gene transfer of neurotrophic factors offers new prospects for the treatment of motor neuron diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thoenen, H., Hughes, R.A. & Sendtner, M. Trophic support of motoneurons: Physiological, pathophysiological, and therapeutic implications. Exp. Neurol. 124, 47–55 (1993).
Henderson, C.E. Neurotrophic factors as therapeutic agents in ALS. Adv. Neurol. 68, 235–240 (1995).
Oppenheim, R.W., Prevette, D., Yin, Q.W., Collins, F. & MacDonald, J. Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251, 1616–1618 (1991).
Oppenheim, R.W., Qin-Wei, Y., Prevette, D. & Yan, P. Brain-derived neurotrophic factor rescues avian motoneurons from Cell death. Nature 360, 755–757 (1992).
Oppenheim, R.W. et al. Developing motor neurons rescued from programmed and axotomy-induced Cell death by GDNF. Nature 373, 344–346 (1995).
Sendtner, M. et al. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358, 502–504 (1992).
Sagot, Y. et al. Polymer encapsulated Cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur.J. Neurosci. 7, 1313–1322 (1995).
Mitsumoto, H. et al. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265, 1107–1110 (1994).
Dittrich, F., Thoenen, H. & Sendner, M. Ciliary neurotrophic factor: Pharmacokinetics and acute-phase response in rat. Ann. Neurol. 35, 151–163 (1994).
Cedarbaum, J.M. et al. A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. Clin. Neuropharmacol. 18, 515–532 (1995).
Miller, R.G. et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann. Neurol. 39, 256–260 (1996).
Jaffe, H.A. et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372–378 (1992).
Rosenfeld, M.A. et al. Adenovirus-mediated transfer of a recombinant alpha 1-anti-trypsin gene to the lung epithelium in vivo. Science 252, 431–434 (1991).
Quantin, B., Perricaudet, L.D., Tajbakhsh, S. & Mandel, J.-L. Adenovirus as an expression vector in muscle Cells in vivo. Proc. Natl. Acad. Sci. USA 89, 2581–2584 (1992).
Stratford-Perricaudet, L.D., Makeh, I., Perricaudet, M. & Briand, P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626–630 (1992).
Vincent, N. et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Cenet. 5, 130–134 (1993).
Akli, S. et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3, 224–228 (1993).
Schmalbruch, H., Jensen, H.S., Bjaerg, M., Kamieniecka, Z. & Kurland, L. A new mouse mutant with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol 50, 192–204 (1991).
Hohn, A., Leibrock, J., Bailey, K. & Barde, Y.A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344, 339–341 (1990).
Maisonpierre, P.C. et al. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science 247, 1446–1451 (1990).
Griesbeck, O., Parsadanian, A.S., Sendtner, M. & Thoenen, H. Expression of neurotrophins in skeletal muscle: Quantitative comparison and significance for motoneuron survival and maintenance of function. J. Neurosci. Res. 42, 21–33 (1995).
Henderson, C.E. et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 363, 266–270 (1993).
Ozcelik, T., Rosenthal, A. & Francke, U. Chromosomal mapping of brain-derived neurotrophic factor and neurotrophin-23 genes in man and mouse. Genomics 10, 569–575 (1991).
Brunialti, A.L.B., Poirier, C., Schmalbruch, H. & Guenet, J.L. The mouse mutation progressive motor neuronopathy (pmn) maps to chromosome 13. Genomics 29, 131–135 (1995).
Johnson, D.R. Extra-toes: A new mutant gene causing multiple abnormalities in the mouse. J. Embryol. Exp. Morphol. 17, 543–581 (1967).
Kennel, P.F. et al. Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease. Neurobiol. Dis. 3, 137–147 (1996).
Willison, R.G. Analysis of electrical activity in healthy and dystrophic muscle in man. J. Neurol. Neurosurg. Psychiatry 27, 386–394 (1964).
Hansen, S. & Ballantyne, J.P. A quantitative electrophysiological study of motor neurone disease. J. Neurol. Neurosurg. Psychiatry 41, 773–783 (1978).
Namba, T., Nakamura, T. & Grob, D. Staining for nerve fiber and cholinesterase activity in fresh frozen sections. Am. J. Clin. Pathol. 47, 74–77 (1967).
Gurney, M.E., Yamamoto, H. & Kwon, Y. Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor. J. Neurosci. 12, 3241–3247 (1992).
Sagot, Y., Tan, S.A., Hammang, J.P., Aebischer, P. & Kato, A.C. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16, 2335–2341 (1996).
Sagot, Y. et al. Bcl-2 overexpression prevents motoneuron Cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15, 7727–7733 (1995).
Langford, L.A. & Schmidt, R.F. An electron microscopic analysis of the left phrenic nerve in the rat. Anat. Rec. 205, 207–213 (1983).
Schnell, L. Schneider, R. Kolbeck, R. Barde, Y.A. & Schwab, M.E. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 367, 170–173 (1994).
Funakoshi, H. et al. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 268, 1495–1499 (1995).
Braun, S., Croizat, B., Lagrange, M.C., Warter, J.M. & Poindron, P. Neurotrophins increase motoneurons' ability to innervate skeletal muscle fibers in rat spinal cord-human muscle cocultures. J. Neurol. Sci. 136, 17–23 (1996).
Lohof, A.M., Ip, N.Y. & Poo, M.-M. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 363, 350–353 (1993).
Stoop, R. & Poo, M.-M. Potentiation of transmitter release by ciliary neurotrophic factor requires somatic signaling. Science 267, 695–699 (1995).
Helgren, M.E. et al. Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 76, 493–504 (1994).
Ghadge, G.D. et al. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther. 2, 132–137 (1995).
Finiels, F. et al. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases. Neuroreport 7, 373–378 (1995).
DiStefano, P.S. et al. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 8, 983–993 (1992).
Hitt, M., Bett, A.J., Prevec, L. & Graham, F.L. Construction and propagation of human adenovirus vectors, in Cell Biology — A Laboratory Handbook, Vol. 1 (ed. Celis, J. E.) 479–490 (Academic Press, San Diego, 1994).
Bottenstein, J.E. Skaper, S.D. Varon, S. & Sato, G. Selective survival of neurons from chick embryo sensory ganglionic dissociates using serum-free supplemented medium. Exp. Cell Res. 125, 183–190 (1980).
Manthorpe, M., Fagnani, R., Skaper, S.D. & Varon, S. An automated colorimetric microassay for neurotrophic factors. Dev. Brain Res. 25, 195–198 (1986).
Bischoff, C. Stålberg, E. Falck, B. & Eeg-Ologsson, K.E. Reference values of motor unit action potentials obtained with multi-MUP analysis. Muscle Nerve 17, 842–851 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haase, G., Kennel, P., Pettmann, B. et al. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med 3, 429–436 (1997). https://doi.org/10.1038/nm0497-429
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0497-429
This article is cited by
-
Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice
Molecular Neurobiology (2019)
-
Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons
Scientific Reports (2016)
-
Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis
Molecular Neurodegeneration (2009)
-
Adult rat spinal cord culture on an organosilane surface in a novel serum-free medium
In Vitro Cellular & Developmental Biology - Animal (2005)
-
ALS, IGF-1 and gene therapy: ‘it's never too late to mend’
Gene Therapy (2004)